The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the devices. The malfunction causes the sensors to deliver incorrect low glucose ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Abbott issued a medical device correction for some ...

"With the Libre device people are scanning on their own an average of 16 times per day, which is quite remarkable and a testament of how easy the technology is to use." But even more interesting for ...

Abbott Diabetes Care has alerted patients that the FreeStyle Libre 3 and Libre 3 Plus glucose sensors may provide incorrect low glucose readings. The FDA posted an Early Alert about the issue on ...

Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...

Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out ...